Laurie Toich, Associate Editor

Apalutamide (Erleada) was approved based on metastasis-free survival, which is a new clinical endpoint.

Tisagenlecleucel (Kymriah) induced remission in a patient with acute lymphoblastic leukemia who was seemingly out of options.

Current production methods make it difficult to mass produce an effective HIV vaccine.

An investigational PDE9A inhibitor did not show efficacy in patients with Alzheimer’s disease.

An executive order allows New York pharmacists to administer the influenza vaccine to children.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Annual Express Scripts drug trend report shows overall reduction in per person prescription drug spending.

Balance and eye movement exercise improved quality of life for patients with multiple sclerosis.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Officials with the FDA have approved Novartis' glatiramer acetate injection (Glatopa) 40-mg/mL for the treatment of multiple sclerosis (MS).

Generic glatiramer acetate injection is now available in a full range of dosing options for multiple sclerosis.

Approximately 78% of survey respondents said that direct and indirect remuneration fees reduce the predictability of cash flow.

Smoking and alcohol consumption may exacerbate the risk of esophageal cancer associated with hot tea.

A cytokine may protect myelin against attacks by the immune system in multiple sclerosis.

Duvelisib monotherapy demonstrated safety and efficacy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.

The 2017/2018 influenza season is the worst in recent history.

The 2017-2018 influenza season is the worst in recent history.

There are currently limited treatments available for scalp psoriasis.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Officials with the FDA have granted approval to abiraterone acetate (Zytiga) tablets in combination with prednisone for the treatment of metastatic high-risk castration-sensitive prostate cancer (CSPC), according to a press release.

FDA expands the indication of abiraterone acetate (Zytiga) to include more patients with prostate cancer.

Immunotherapy combination outperforms chemotherapy in patients with advanced or metastatic renal cell carcinoma.

Breast cancer survivors are more likely to die from heart disease than cancer.

Officials with the FDA have approved 2 different fixed dose drugs indicated to treat HIV-1: Symfi Lo tablets and Biktarvy.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

New combination therapy gains approval for adult and pediatric patients with HIV-1.